Loading…

A correlation between capsid protein VP2 and the plaque morphology of African horse sickness virus in cell culture

The attenuated live virus vaccine that is used in South Africa to protect against African horse sickness infection was developed more than 50 years ago. With the selection of the vaccine strains by cell culture passage, a correlation between the size of plaques formed in monolayer Vero cultures and...

Full description

Saved in:
Bibliographic Details
Published in:Virus genes 2018-08, Vol.54 (4), p.527-535
Main Authors: Schade-Weskott, Mathilde L., van Schalkwyk, Antoinette, Koekemoer, J. J. O.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c415t-88463641805064f7218f715ad776256f8f37cd9dbd299a7eb0aadba8f384db893
cites cdi_FETCH-LOGICAL-c415t-88463641805064f7218f715ad776256f8f37cd9dbd299a7eb0aadba8f384db893
container_end_page 535
container_issue 4
container_start_page 527
container_title Virus genes
container_volume 54
creator Schade-Weskott, Mathilde L.
van Schalkwyk, Antoinette
Koekemoer, J. J. O.
description The attenuated live virus vaccine that is used in South Africa to protect against African horse sickness infection was developed more than 50 years ago. With the selection of the vaccine strains by cell culture passage, a correlation between the size of plaques formed in monolayer Vero cultures and attenuation of virus virulence in horses was found. The large plaque phenotype was used as an indication of cell culture adaptation and strongly correlated with attenuation of virulence in horses. There was never any investigation into the genetic causes of either the variation in plaque size, or the loss of virulence. An understanding of the underlying mechanisms of attenuation would benefit the production of a safer AHSV vaccine. To this end, the genomes of different strains of two African horse sickness isolates, producing varying plaque sizes, were compared and the differences between them identified. This comparison suggested that proteins VP2, VP3, VP5 and NS3 were most likely involved in the determination of the plaque phenotype. Comparison between genome sequences (obtained from GenBank) of low and high passage strains from two additional serotypes indicated that VP2 was the only protein with amino acid substitutions in all four serotypes. The amino acid substitutions all occurred within the same hydrophilic area, resulting in increased hydrophilicity of VP2 in the large plaque strains.
doi_str_mv 10.1007/s11262-018-1567-y
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2035708294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2035708294</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-88463641805064f7218f715ad776256f8f37cd9dbd299a7eb0aadba8f384db893</originalsourceid><addsrcrecordid>eNp1kU9LHDEYh0NRdLV-gF4k4MXLtEkmkz_HRVoVBD2o9BYyyTvu2NlkmsxU9ts3y1qFgqdA8ry__F4ehL5Q8pUSIr9lSplgFaGqoo2Q1eYTWtBGskpr_nMPLYhmpFKN0IfoKOdnQohSjB-gQ6ZlTaSoFygtsYspwWCnPgbcwvQCELCzY-49HlOcoA_48Y5hGzyeVoDHwf6eAa9jGldxiE8bHDu87FLvbMCrmDLg3LtfAXLGf_o0Z1wCHAwDdvMwzQk-o_3ODhlOXs9j9PDj-_3FVXVze3l9sbypHKfNVCnFRS04VaQhgneSUdVJ2lgvpWCN6FRXS-e1bz3T2kpoibW-teVacd8qXR-j811u2aI0zpNZ93lbxAaIczaM1I0kimle0LP_0Oc4p1DabSmuJBVMForuKJdizgk6M6Z-bdPGUGK2QsxOiClCzFaI2ZSZ09fkuV2Df5v4Z6AAbAfk8hSeIL1__XHqX3frlsw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2034871627</pqid></control><display><type>article</type><title>A correlation between capsid protein VP2 and the plaque morphology of African horse sickness virus in cell culture</title><source>Springer Nature</source><creator>Schade-Weskott, Mathilde L. ; van Schalkwyk, Antoinette ; Koekemoer, J. J. O.</creator><creatorcontrib>Schade-Weskott, Mathilde L. ; van Schalkwyk, Antoinette ; Koekemoer, J. J. O.</creatorcontrib><description>The attenuated live virus vaccine that is used in South Africa to protect against African horse sickness infection was developed more than 50 years ago. With the selection of the vaccine strains by cell culture passage, a correlation between the size of plaques formed in monolayer Vero cultures and attenuation of virus virulence in horses was found. The large plaque phenotype was used as an indication of cell culture adaptation and strongly correlated with attenuation of virulence in horses. There was never any investigation into the genetic causes of either the variation in plaque size, or the loss of virulence. An understanding of the underlying mechanisms of attenuation would benefit the production of a safer AHSV vaccine. To this end, the genomes of different strains of two African horse sickness isolates, producing varying plaque sizes, were compared and the differences between them identified. This comparison suggested that proteins VP2, VP3, VP5 and NS3 were most likely involved in the determination of the plaque phenotype. Comparison between genome sequences (obtained from GenBank) of low and high passage strains from two additional serotypes indicated that VP2 was the only protein with amino acid substitutions in all four serotypes. The amino acid substitutions all occurred within the same hydrophilic area, resulting in increased hydrophilicity of VP2 in the large plaque strains.</description><identifier>ISSN: 0920-8569</identifier><identifier>EISSN: 1572-994X</identifier><identifier>DOI: 10.1007/s11262-018-1567-y</identifier><identifier>PMID: 29730763</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>African horse sickness ; Amino acids ; Biomedical and Life Sciences ; Biomedicine ; Capsid protein ; Cell culture ; Cytology ; Genomes ; Medical Microbiology ; Phenotypes ; Plant Sciences ; Plaques ; Serotypes ; Strains (organisms) ; Vaccines ; Virology ; Virulence ; VP3 protein</subject><ispartof>Virus genes, 2018-08, Vol.54 (4), p.527-535</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2018</rights><rights>Virus Genes is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-88463641805064f7218f715ad776256f8f37cd9dbd299a7eb0aadba8f384db893</citedby><cites>FETCH-LOGICAL-c415t-88463641805064f7218f715ad776256f8f37cd9dbd299a7eb0aadba8f384db893</cites><orcidid>0000-0003-4130-6543</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29730763$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schade-Weskott, Mathilde L.</creatorcontrib><creatorcontrib>van Schalkwyk, Antoinette</creatorcontrib><creatorcontrib>Koekemoer, J. J. O.</creatorcontrib><title>A correlation between capsid protein VP2 and the plaque morphology of African horse sickness virus in cell culture</title><title>Virus genes</title><addtitle>Virus Genes</addtitle><addtitle>Virus Genes</addtitle><description>The attenuated live virus vaccine that is used in South Africa to protect against African horse sickness infection was developed more than 50 years ago. With the selection of the vaccine strains by cell culture passage, a correlation between the size of plaques formed in monolayer Vero cultures and attenuation of virus virulence in horses was found. The large plaque phenotype was used as an indication of cell culture adaptation and strongly correlated with attenuation of virulence in horses. There was never any investigation into the genetic causes of either the variation in plaque size, or the loss of virulence. An understanding of the underlying mechanisms of attenuation would benefit the production of a safer AHSV vaccine. To this end, the genomes of different strains of two African horse sickness isolates, producing varying plaque sizes, were compared and the differences between them identified. This comparison suggested that proteins VP2, VP3, VP5 and NS3 were most likely involved in the determination of the plaque phenotype. Comparison between genome sequences (obtained from GenBank) of low and high passage strains from two additional serotypes indicated that VP2 was the only protein with amino acid substitutions in all four serotypes. The amino acid substitutions all occurred within the same hydrophilic area, resulting in increased hydrophilicity of VP2 in the large plaque strains.</description><subject>African horse sickness</subject><subject>Amino acids</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Capsid protein</subject><subject>Cell culture</subject><subject>Cytology</subject><subject>Genomes</subject><subject>Medical Microbiology</subject><subject>Phenotypes</subject><subject>Plant Sciences</subject><subject>Plaques</subject><subject>Serotypes</subject><subject>Strains (organisms)</subject><subject>Vaccines</subject><subject>Virology</subject><subject>Virulence</subject><subject>VP3 protein</subject><issn>0920-8569</issn><issn>1572-994X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kU9LHDEYh0NRdLV-gF4k4MXLtEkmkz_HRVoVBD2o9BYyyTvu2NlkmsxU9ts3y1qFgqdA8ry__F4ehL5Q8pUSIr9lSplgFaGqoo2Q1eYTWtBGskpr_nMPLYhmpFKN0IfoKOdnQohSjB-gQ6ZlTaSoFygtsYspwWCnPgbcwvQCELCzY-49HlOcoA_48Y5hGzyeVoDHwf6eAa9jGldxiE8bHDu87FLvbMCrmDLg3LtfAXLGf_o0Z1wCHAwDdvMwzQk-o_3ODhlOXs9j9PDj-_3FVXVze3l9sbypHKfNVCnFRS04VaQhgneSUdVJ2lgvpWCN6FRXS-e1bz3T2kpoibW-teVacd8qXR-j811u2aI0zpNZ93lbxAaIczaM1I0kimle0LP_0Oc4p1DabSmuJBVMForuKJdizgk6M6Z-bdPGUGK2QsxOiClCzFaI2ZSZ09fkuV2Df5v4Z6AAbAfk8hSeIL1__XHqX3frlsw</recordid><startdate>20180801</startdate><enddate>20180801</enddate><creator>Schade-Weskott, Mathilde L.</creator><creator>van Schalkwyk, Antoinette</creator><creator>Koekemoer, J. J. O.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4130-6543</orcidid></search><sort><creationdate>20180801</creationdate><title>A correlation between capsid protein VP2 and the plaque morphology of African horse sickness virus in cell culture</title><author>Schade-Weskott, Mathilde L. ; van Schalkwyk, Antoinette ; Koekemoer, J. J. O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-88463641805064f7218f715ad776256f8f37cd9dbd299a7eb0aadba8f384db893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>African horse sickness</topic><topic>Amino acids</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Capsid protein</topic><topic>Cell culture</topic><topic>Cytology</topic><topic>Genomes</topic><topic>Medical Microbiology</topic><topic>Phenotypes</topic><topic>Plant Sciences</topic><topic>Plaques</topic><topic>Serotypes</topic><topic>Strains (organisms)</topic><topic>Vaccines</topic><topic>Virology</topic><topic>Virulence</topic><topic>VP3 protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schade-Weskott, Mathilde L.</creatorcontrib><creatorcontrib>van Schalkwyk, Antoinette</creatorcontrib><creatorcontrib>Koekemoer, J. J. O.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Virus genes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schade-Weskott, Mathilde L.</au><au>van Schalkwyk, Antoinette</au><au>Koekemoer, J. J. O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A correlation between capsid protein VP2 and the plaque morphology of African horse sickness virus in cell culture</atitle><jtitle>Virus genes</jtitle><stitle>Virus Genes</stitle><addtitle>Virus Genes</addtitle><date>2018-08-01</date><risdate>2018</risdate><volume>54</volume><issue>4</issue><spage>527</spage><epage>535</epage><pages>527-535</pages><issn>0920-8569</issn><eissn>1572-994X</eissn><abstract>The attenuated live virus vaccine that is used in South Africa to protect against African horse sickness infection was developed more than 50 years ago. With the selection of the vaccine strains by cell culture passage, a correlation between the size of plaques formed in monolayer Vero cultures and attenuation of virus virulence in horses was found. The large plaque phenotype was used as an indication of cell culture adaptation and strongly correlated with attenuation of virulence in horses. There was never any investigation into the genetic causes of either the variation in plaque size, or the loss of virulence. An understanding of the underlying mechanisms of attenuation would benefit the production of a safer AHSV vaccine. To this end, the genomes of different strains of two African horse sickness isolates, producing varying plaque sizes, were compared and the differences between them identified. This comparison suggested that proteins VP2, VP3, VP5 and NS3 were most likely involved in the determination of the plaque phenotype. Comparison between genome sequences (obtained from GenBank) of low and high passage strains from two additional serotypes indicated that VP2 was the only protein with amino acid substitutions in all four serotypes. The amino acid substitutions all occurred within the same hydrophilic area, resulting in increased hydrophilicity of VP2 in the large plaque strains.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>29730763</pmid><doi>10.1007/s11262-018-1567-y</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-4130-6543</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0920-8569
ispartof Virus genes, 2018-08, Vol.54 (4), p.527-535
issn 0920-8569
1572-994X
language eng
recordid cdi_proquest_miscellaneous_2035708294
source Springer Nature
subjects African horse sickness
Amino acids
Biomedical and Life Sciences
Biomedicine
Capsid protein
Cell culture
Cytology
Genomes
Medical Microbiology
Phenotypes
Plant Sciences
Plaques
Serotypes
Strains (organisms)
Vaccines
Virology
Virulence
VP3 protein
title A correlation between capsid protein VP2 and the plaque morphology of African horse sickness virus in cell culture
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T04%3A22%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20correlation%20between%20capsid%20protein%20VP2%20and%20the%20plaque%20morphology%20of%20African%20horse%20sickness%20virus%20in%20cell%20culture&rft.jtitle=Virus%20genes&rft.au=Schade-Weskott,%20Mathilde%20L.&rft.date=2018-08-01&rft.volume=54&rft.issue=4&rft.spage=527&rft.epage=535&rft.pages=527-535&rft.issn=0920-8569&rft.eissn=1572-994X&rft_id=info:doi/10.1007/s11262-018-1567-y&rft_dat=%3Cproquest_cross%3E2035708294%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-88463641805064f7218f715ad776256f8f37cd9dbd299a7eb0aadba8f384db893%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2034871627&rft_id=info:pmid/29730763&rfr_iscdi=true